BioNexus Gene Lab Corp (BGLC) Stock Price, Quote, News & History

BGLCNASDAQ
$2.24
-0.08-3.45%
At close: May 29, 5:00 PM EST
$2.31
-0.01-0.43%
Pre-Market: 4:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-1.16M
Investing Cash Flow (TTM)
946.41K
Financing Cash Flow (TTM)
359.41K
Free Cash Flow (TTM)
-1.19M
Capital Expenditure (TTM)
-28.24K
Net Change in Cash (TTM)
143.84K

Valuation Metrics

Enterprise Value
$1.67M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.85
PB Ratio (TTM)
0.67
Earnings Yield % (TTM)
-66.29%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.35

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$3.96M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$2.24
Volume / Avg.
142.00 / 13.27K
Day Range
- - -
52 Wk Range
1.92 - 15.60
Market Cap
$5.58M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
0.52%
Days to Cover
2.19

About

Sector
Industrials
Industry
Trading Companies & Distributors
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw mat...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioNexus Gene Lab (BGLC) stock?

A

You can purchase shares of BioNexus Gene Lab (NASDAQ:BGLC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioNexus Gene Lab (BGLC) competitors?

A

There are no as such competitors for BioNexus Gene Lab.

Q

What is the forecast, or price target, for BioNexus Gene Lab (BGLC) stock?

A

There is no analysis for BioNexus Gene Lab to provide a consensus price target.

Q

What is the current price for BioNexus Gene Lab (BGLC)?

A

The stock price for BioNexus Gene Lab (NASDAQ: BGLC) is $2.31 last updated June 1, 2026 at 7:07 PM EDT.

Q

Does BioNexus Gene Lab (BGLC) pay a dividend?

A

There are no upcoming dividends for BioNexus Gene Lab.

Q

When is BioNexus Gene Lab (NASDAQ:BGLC) reporting earnings?

A

BioNexus Gene Lab does not have any upcoming earnings scheduled.

Q

Is BioNexus Gene Lab (BGLC) going to split?

A

There is no upcoming split for BioNexus Gene Lab.

Q

What sector and industry does BioNexus Gene Lab (BGLC) operate in?

A

BioNexus Gene Lab is in the Industrials sector and Trading Companies & Distributors industry. They are listed on the NASDAQ.